Mechanisms of C-peptide-mediated rescue of low O2-induced ATP release from erythrocytes of humans with type 2 diabetes

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 308, Issue 5, 2015, Pages R411-R418

  Richards, Jennifer P ^a   Bowles, Elizabeth A ^a   Gordon, Weston R ^a   Ellsworth, Mary L ^a   Stephenson, Alan H ^a   Sprague, Randy S ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Adenosine triphosphate; G protein coupled receptor 146; Microcirculation; Red blood cell; Soluble guanylyl cyclise

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; ACETYLSALICYLIC ACID; ADENOSINE TRIPHOSPHATE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CYCLIC GMP; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GUANYLATE CYCLASE INHIBITOR; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; OXYGEN; PROTEIN KINASE C; TADALAFIL; ZAPRINAST; ANTIDIABETIC AGENT; CELL RECEPTOR; GUANYLATE CYCLASE; PHOSPHODIESTERASE V INHIBITOR; PROTEIN KINASE INHIBITOR; SOLUBLE GUANYLYL CYCLASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; TONOMETER; AGED; ANTAGONISTS AND INHIBITORS; BLOOD; CASE CONTROL STUDY; CELL HYPOXIA; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; METABOLISM; MIDDLE AGED; VERY ELDERLY;

ADENOSINE TRIPHOSPHATE; ADULT; AGED; AGED, 80 AND OVER; C-PEPTIDE; CASE-CONTROL STUDIES; CELL HYPOXIA; CYCLIC GMP; DIABETES MELLITUS, TYPE 2; ERYTHROCYTES; FEMALE; GUANYLATE CYCLASE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; OXYGEN; PHOSPHODIESTERASE 5 INHIBITORS; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION;

EID: 84923886313     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00420.2014     Document Type: Article

References (50)

1. Adderley SP, Dufaux EA, Sridharan M, Bowles EA, Hanson MS, Stephenson AH, Ellsworth ML, Sprague RS. Iloprost- and isoproterenol- induced increases in cAMP are regulated by different phosphodiesterases in erythrocytes of both rabbits and humans. Am J Physiol Heart Circ Physiol 296: H1617–H1624, 2009.
2. Adderley SP, Sprague RS, Stephenson AH, Hanson MS. Regulation of cAMP by phosphodiesterases in erythrocytes. Pharmacol Rep 62: 475–482, 2010.
3. Al-Rasheed NM, Meakin F, Royal EL, Lewington AJ, Brown J, Willars GB, Brunskill NJ. Potent activation of multiple signalling pathways by C-peptide in opossum kidney proximal tubular cells. Diabetologia 47: 987–997, 2004.
4. Al-Rasheed NM, Willars GB, Brunskill NJ. C-peptide signals via Gαi to protect against TNF-_-mediated apoptosis of opossum kidney proximal tubular cells. J Am Soc Nephrol 17: 986–995, 2006.
5. Bauer TA, Reusch JE, Levi M, Regensteiner JG. Skeletal muscle deoxygenation after the onset of moderate exercise suggests slowed microvascular blood flow kinetics in type 2 diabetes. Diabetes Care 30: 2880–2885, 2007.
6. Bayewitch ML, Avidor-Reiss T, Levy R, Pfeuffer T, Nevo I, Simonds WF, Vogel Z. Differential modulation of adenylyl cyclases I and II by various G beta subunits. J Biol Chem 273: 2273–2276, 1998.
7. Bazalo G, Weiss R, Clark N, Alemayehu B, Forma F, Ingram G. Effect of drug therapy on HEDIS measurements of HbA1c control in diabetes patients. Managed Care 18: 40–44, 2009.
8. Brown CD, Ghali HS, Zhao Z, Thomas LL, Friedman EA. Association of reduced red blood cell deformability and diabetic nephropathy. Kidney Int 67: 295–300, 2005.
9. Dalziel HH, Westfall DP. Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization. Pharmacol Rev 46: 449–466, 1994.
10. De La Tour DD, Raccah D, Jannot MF, Coste T, Rougerie C, Vague P. Erythrocyte Na/K-ATPase activity and diabetes: relationship with C-peptide level. Diabetologia 41: 1080–1084, 1998.
11. Dietrich HH, Ellsworth ML, Sprague RS, Dacey RG Jr. Red blood cell regulation of microvascular tone through adenosine triphosphate. Am J Physiol Heart Circ Physiol 278: H1294–H1298, 2000.
12. Ellis CG, Goldman D, Hanson M, Stephenson AH, Milkovich S, Benlamri A, Ellsworth ML, Sprague RS. Defects in oxygen supply to skeletal muscle of prediabetic ZDF rats. Am J Physiol Heart Circ Physiol 298: H1661–H1670, 2010.
13. Ellsworth ML. Red blood cell-derived ATP as a regulator of skeletal muscle perfusion. Med Sci Sports Exerc 36: 35–41, 2004.
14. Federman AD, Conklin BR, Schrader KA, Reed RR, Bourne HR. Hormonal stimulation of adenylyl cyclase through Gi-protein, α β subunits. Nature 356: 159–161, 1992.
15. Forst T, De La Tour DD, Kunt T, Pfutzner A, Goitom K, Pohlmann T, Schneider S, Johansson BL, Wahren J, Lobig M, Engelbach M, Beyer J, Vague P. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I. Clin Sci (Lond) 98: 283–290, 2000.
16. Forst T, Hach T, Kunt T, Weber MM, Pfutzner A. Molecular effects of C-peptide in microvascular blood flow regulation. Rev Diabet Stud 6: 159–167, 2009.
17. Galuska D, Pirkmajer S, Barres R, Ekberg K, Wahren J, Chibalin AV. C-peptide increases Na,K-ATPase expression via PKC- and MAP kinase-dependent activation of transcription factor ZEB in human renal tubular cells. PLoS One 6: e28294, 2011.
18. Gonzalez-Alonso J, Olsen DB, Saltin B. Erythrocyte and the regulation of human skeletal muscle blood flow and oxygen delivery: role of circulating ATP. Circ Res 91: 1046–1055, 2002.
19. Govekar RB, Zingde SM. Protein kinase C isoforms in human erythrocytes. Ann Hematol 80: 531–534, 2001.
20. Hach T, Forst T, Kunt T, Ekberg K, Pfutzner A, Wahren J. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients. Exp Diabetes Res 2008: 730594, 2008.
21. Hanson MS, Ellsworth ML, Achilleus D, Stephenson AH, Bowles EA, Sridharan M, Adderley S, Sprague RS. Insulin inhibits low oxygeninduced ATP release from human erythrocytes: implication for vascular control. Microcirculation 16: 424–433, 2009.
22. Hanson MS, Stephenson AH, Bowles EA, Sprague RS. Insulin inhibits human erythrocyte cAMP accumulation and ATP release: role of phosphodiesterase 3 and phosphoinositide 3-kinase. Exp Biol Med (Maywood) 235: 256–262, 2010.
23. Heding LG, Rasmussen SM. Human C-peptide in normal and diabetic subjects. Diabetologia 11: 201–206, 1975.
24. Hills CE, Brunskill NJ. Cellular and physiological effects of C-peptide. Clin Sci (Lond) 116: 565–574, 2009.
25. Holownia P, Bishop E, Newman DJ, John WG, Price CP. Adaptation of latex-enhanced assay for percent glycohemoglobin to a Dade Dimension analyzer. Clin Chem 43: 76–84, 1997.
26. Horwitz DL, Starr JI, Mako ME, Blackard WG, Rubenstein AH. Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. J Clin Invest 55: 1278–1283, 1975.
27. Iancu RV, Jones SW, Harvey RD. Compartmentation of cAMP signaling in cardiac myocytes: a computational study. Biophys J 92: 3317–3331, 2007.
28. Juarez DT, Sentell T, Tokumaru S, Goo R, Davis JW, Mau MM. Factors associated with poor glycemic control or wide glycemic variability among diabetes patients in Hawaii, 2006–2009. Prevent Chronic Dis 9: 120065, 2012.
29. Juhan I, Vague P, Buonocore M, Moulin JP, Jouve R, Vialettes B. Abnormalities of erythrocyte deformability and platelet aggregation in insulin-dependent diabetics corrected by insulin in vivo and in vitro. Lancet 1: 535–537, 1982.
30. Kennedy C, Delbro D, Burnstock G. P2-purinoceptors mediate both vasodilation (via the endothelium) and vasoconstriction of the isolated rat femoral artery. Eur J Pharmacol 107: 161–168, 1985.
31. Kunt T, Schneider S, Pfutzner A, Goitum K, Engelbach M, Schauf B, Beyer J, Forst T. The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type I diabetes mellitus. Diabetologia 42: 465–471, 1999.
32. Louis JC, Revel MO, Zwiller J. Activation of soluble guanylate cyclase through phosphorylation by protein kinase C in intact PC12 cells. Biochim Biophys Acta 1177: 299–306, 1993.
33. Manganiello VC, Taira M, Degerman E, Belfrage P. Type III cGMPinhibited cyclic nucleotide phosphodiesterases (PDE3 gene family). Cell Signal 7: 445–455, 1995.
34. Nordquist L, Johansson M. Proinsulin C-peptide: friend or foe in the development of diabetes-associated complications? Vasc Health Risk Manag 4: 1283–1288, 2008.
35. Olearczyk JJ, Stephenson AH, Lonigro AJ, Sprague RS. Heterotrimeric G protein Gi is involved in a signal transduction pathway for ATP release from erythrocytes. Am J Physiol Heart Circ Physiol 286: H940–H945, 2004.
36. Olearczyk JJ, Stephenson AH, Lonigro AJ, Sprague RS. NO inhibits signal transduction pathway for ATP release from erythrocytes via its action on heterotrimeric G protein Gi. Am J Physiol Heart Circ Physiol 287: H748–H754, 2004.
37. Richards JP, Stephenson AH, Ellsworth ML, Sprague RS. Synergistic effects of C-peptide and insulin on low O2-induced ATP release from human erythrocytes. Am J Physiol Regul Integr Comp Physiol 305: R1331–R1336, 2013.
38. Richards JP, Yosten GL, Kolar GR, Jones CW, Stephenson AH, Ellsworth ML, Sprague RS. Low O2-induced ATP release from erythrocytes of humans with Type 2 diabetes is restored by physiological ratios of C-peptide and insulin. Am J Physiol Regul Integr Comp Physiol 307: R862–R868, 2014.
39. Sprague R, Bowles E, Stumpf M, Ricketts G, Freidman A, Hou WH, Stephenson A, Lonigro A. Rabbit erythrocytes possess adenylyl cyclase type II that is activated by the heterotrimeric G proteins Gs and Gi. Pharmacol Rep 57 Suppl: 222–228, 2005.
40. Sprague RS, Bowles EA, Achilleus D, Stephenson AH, Ellis CG, Ellsworth ML. A selective phosphodiesterase 3 inhibitor rescues low PO2- induced ATP release from erythrocytes of humans with type 2 diabetes: implication for vascular control. Am J Physiol Heart Circ Physiol 301: H2466–H2472, 2011.
41. Sprague RS, Bowles EA, Olearczyk JJ, Stephenson AH, Lonigro AJ. The role of G protein subunits in the release of ATP from human erythrocytes. J Physiol Pharmacol 53: 667–674, 2002.
42. Sprague RS, Ellsworth ML, Stephenson AH, Lonigro AJ. Participation of cAMP in a signal-transduction pathway relating erythrocyte deformation to ATP release. Am J Physiol Cell Physiol 281: C1158–C1164, 2001.
43. Sprague RS, Goldman D, Bowles EA, Achilleus D, Stephenson AH, Ellis CG, Ellsworth ML. Divergent effects of low-O2 tension and iloprost on ATP release from erythrocytes of humans with type 2 diabetes: implications for O2 supply to skeletal muscle. Am J Physiol Heart Circ Physiol 299: H566–H573, 2010.
44. Sprague RS, Stephenson AH, Bowles EA, Stumpf MS, Lonigro AJ. Reduced expression of Gi in erythrocytes of humans with type 2 diabetes is associated with impairment of both cAMP generation and ATP release. Diabetes 55: 3588–3593, 2006.
45. Steiner DF. The proinsulin C-peptide—a multirole model. Exp Diabesity Res 5: 7–14, 2004.
46. Tsimaratos M, Roger F, Chabardes D, Mordasini D, Hasler U, Doucet A, Martin PY, Feraille E. C-peptide stimulates Na+,K+-ATPase activity via PKC alpha in rat medullary thick ascending limb. Diabetologia 46: 124–131, 2003.
47. Wallerath T, Kunt T, Forst T, Closs EI, Lehmann R, Flohr T, Gabriel M, Schafer D, Gopfert A, Pfutzner A, Beyer J, Forstermann U. Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide. Nitric Oxide 9: 95–102, 2003.
48. Williamson JR, Gardner RA, Boylan CW, Carroll GL, Chang K, Marvel JS, Gonen B, Kilo C, Tran-Son-Tay R, Sutera SP. Microrheologic investigation of erythrocyte deformability in diabetes mellitus. Blood 65: 283–288, 1985.
49. Yosten GL, Kolar GR, Redlinger LJ, SamsonWK.Evidence for an interaction between proinsulin C-peptide and GPR 146. J Endocrinol 218: B1–B8, 2013.
50. Zhong Z, Davidescu A, Ehren I, Ekberg K, Jornvall H, Wahren J, Chibalin AV. C-peptide stimulates ERK1/2 and JNK MAP kinases via activation of protein kinase C in human renal tubular cells. Diabetologia 48: 187–197, 2005.